SlideShare a Scribd company logo
www.acg-associatedcapsules.com
ACG Associated Capsules’
A Primer on Hard
Gelatin Capsule
Manufacturing
Understanding what goes into making high-quality empty hard gelatin
capsules.
Page | 2
www.acg-associatedcapsules.com
Introduction
Hard gelatin capsule shells are used as soluble containers for incorporation of drugs or nutritional
supplements, usually in the form of powders, pellets or granules in the healthcare industry. They are
commonly intended for oral administration having its advantages over other dosage forms that are
used widely by pharmaceutical companies to develop different medicaments and ensure stability of
the product throughout the shelf life. Since it serves as a major excipient for the manufacture of
pharmaceutical products, the quality attributes of hard capsule shells is very vital for performance
and stability of the final product.
Pharmaceutical products are categorized as high quality and high risk product administered to fight
various types of acute and chronic illnesses where the performance of the product should be
reproducible every time it is administered. The capsule shell consists of two cylindrical parts i.e. the
cap and body; both are open at one extreme. Other extreme of both is hemispherical; the open end
of cap overlaps the open end of body and maintains a closure with a typical lock system. Hence, it is
very important that the product achieves the label claim as set forth and is not contaminated and
readily available to the patients. Benchmarking of developments and manufacturing processes in the
pharmaceutical industry as against other industries led to the concept of Quality by Design or QbD.
Over the past few years, QbD has gained considerable acceptance throughout pharmaceutical
industry and has been successfully applied. The key quality attributes of capsules that determine the
process ability on the high speed filling machine are the dimensional characteristics and weight
variability.
The potential variations of empty hard capsules as an input material and its potential impact on
finished product quality has been studied and high consistency within the specification of the critical
quality parameters is confirmed. Annual product quality review needs to be performed using defined
sampling size against set of verification criteria. The built-in quality approach begins at the
development stage of new product where even factors impacting the performance of hard capsules
i.e. formulation, filling machine type, etc., is given due consideration. The selection of proper raw
material, the process validations and stability studies are to be conducted for suitability. The process
conditions should be maintained along with appropriate in-process quality checks. Final release of
product can be done by QA after product and document review. The data on process capability,
trends of quality parameters, technical specification and the evaluation procedure should be
maintained and submitted based on the current level of quality standards.
Manufacturing of Hard Gelatin Capsule Shells
Raw Materials
The manufacture of hard gelatin capsule shells is by physical molding process where gelatin & water
are the basic raw materials required. Colorants & opacifiers are optional and are used as per
requirement.
Gelatin
Gelatin from bovine source is the main raw material used in the manufacturing of hard capsule
shells. Bovine gelatin used is derived from bones and hides of healthy animals that have been
certified as fit for human consumption by a veterinary official at slaughtering. The tissues used in the
manufacture of gelatin are free from specified risk material. It should be ensured that bovine gelatin
conforms to TSE/BSE regulation as applicable to the country of use. All gelatin used must confirm to
applicable pharmacopoeia and food regulation like:
· Regulation (EC) No 999/2001
Page | 3
www.acg-associatedcapsules.com
· Regulation (EC) No 853 2004
· Commission directive 2003/63/EC and European Pharmacopoeia - 1483 evidenced by
certificate of suitability.
· USFDA Sept 1997 Guidance to industry for sourcing and processing of gelatin to reduce the
potential risk posed by BSE in FDA regulated product.
· USFDA 21 CFR parts 189, 589, 700 pertaining to prohibited cattle material in human food,
drugs and cosmetics and animal feeds.
· USFDA 9 CFR part 94.18 pertaining to restriction on important edible products from
ruminants due to BSE.
· USFDA 9 CFR part 94.19 on gelatin from ruminants that have not been in any region where
BSE exists
Food Colors
Food colorants applicable to the regulatory standards must be used for the manufacturing of hard
gelatin capsules. Colors that require FDA approval as per customer intent bear the FDA lot number.
Colors not requiring FDA approval, as per local regulation or customer, should be accompanied by
certificate of analysis complying with applicable standard. Stock solutions of food colors are
prepared and the concentration of solution is checked by QC, and suggested for any corrections
required. As per the recipe, known concentration of color stock solutions are added to mucilage to
achieve the required shade conforming to the primary master sample.
Purified Water
Purified water conforming to applicable pharmacopoeia is to be used for preparing mucilage for
capsule manufacturing. The pre-treatment of water is carried out with sodium hypochlorite and
flocculating agents. The pre-treated water is filtered through multigrain, sand filters softened and
demineralized. Demineralized (DM) water is monitored for conductivity and pH. DM water plant is
interlocked for regeneration when pH and conductivity is out of limit. UV lamps are installed at
critical points for control of microbial contamination. The DM water is pumped through 0.2 µ filters.
The distribution and storage is non-corrosive stainless steel. The purified water is maintained at
temperature of 82+ 2 degrees and is under continuous hot loop circulation. In addition, raw water is
checked for hardness daily. User points are also sampled and tested for Micro, hardness, pH,
conductivity, potability on a daily and weekly basis.
Material Movement
After receiving the material, it is quarantined bearing appropriate sticker and the lot information.
Containers are sampled as per the sampling plan by QC under reverse laminar air flow one at a time
and labeled. The sampled material is tested for compliance to the defined pharmacopoeial and in
house specifications. The approved materials are identified by appropriate approved labeling which
mentions the analytical report number and the reassessment date. Storage of quarantine and
approved material is segregated. Only raw materials, which are approved by QC and within the shelf
life, are dispensed and issued to production. The dispensing is carried out based on system
generated recipe for the particular batch; this is done on suitable calibrated weighing scale. Product
is identified by labels, identification cards, and tags at all stages of production.
Raw materials that do not confirm to specifications are labeled with rejected label and stored
segregated in secured manner to prevent inadvertent use till material is returned back to the
vendor. All stages of bulk manufacturing area are designated for in-process rejects and are kept
under control.
Page | 4
www.acg-associatedcapsules.com
PROCESS CONTROLS
Figure-1 - Schematic of Raw Material Movement Prior to Dipping
Bulk Manufacturing
Mucilage Preparation
The mucilage is prepared in stainless steel jacketed vessels with impeller for uniform mixing of the
additives in controlled environment conditions. The clear transparent gelatin solution is withdrawn
in feed tanks that are also stainless steel jacketed vessel. Each color shade can be identified by
unique identification number and the recipe is stored in the system. The colorants are added as per
the recipe in the feed tank and the final shade is approved by QA. The temperature of gelatin
solution is maintained at 50 +1 degree throughout the process. The gelatin solution should be
converted within 18 hours to ensure there is no risk of microbial growth in the solution. Adequate
in-process checks are done to ensure right quality of mucilage is issued for manufacturing.
Equipment surfaces that come in contact with in-process material/finished product, should be non-
reactive, non-corrosive and non-additive. The pin bars have typical lock pattern and vents engraved
on them for proper locking and to facilitate displacement of air at the time of closing on high-speed
filling machines. The cap of capsule also has pre-locks to reduce possibility of premature separation
of cap and body during transportation and conveying prior to filling. The hard gelatin capsule
machine comprises four main sections:
Page | 5
www.acg-associatedcapsules.com
Dipping Section
The dip baths hold the gelatin solution for molding. The design of the dip bath is developed to
ensure proper weight spread. The dip bath’s central and parellal functions are monitored to ensure
equal picking up of gelatin at all the four corners of the dipping section. The pin bars undergo one-
and-a-half rotation to ensure uniform distribution of gelatin solution in the dome portion. The pin
bars are reconditioned and polished before re-dipping in the gelatin solution.
Drying Section
The dipped pin bars form stacks and are carried on conveyor to drying section. There are different
drying hoods in the drying section. The temperature and relative humidity in each drying zone is
controlled by maintaining the dew point for proper drying of capsule.
Auto Head Section
The dried shells are carried on a conveyor into the auto head section. The dried capsules are
stripped, cut and joined in this section. The cap and body are held separately in the collet ring and
are cut with specially-designed ceramic blades to the required length. The frequency of blade
checking and replacement is defined and closely monitored.
Air Transfer System
The capsules manufactured are transferred to moisture stabilization chamber through venturi. The
capsules are flushed with controlled air for stabilization of moisture. The capsules, after joining, are
ejected on series of mechanical sorter where defects generated as a virtue of process are trapped
and prevented from further processing. Sorters such as:
Diametrical Sorter: The diametrical sorter is a go-no-go sieve with openings of the size of cap
diameter, allowing any damaged or disfigured capsules are trapped.
Nail Bed Sorter: Usually, the ring created after the cap and body are cut is sucked through vacuum.
However, if not trapped by vacuum, these rings can be trapped in the bed of nails installed. The nail
bed sorter also catches any loose caps or bodies.
Loose Body Sorter: This sorter consists of a rotating disc with spacers between two discs, exactly the
size more than the outer diameter of body and slightly less than the inner diameter of cap. Due to
the rotational movement, only good capsules get carried over to the hopper of venturi. All loose
bodies are collected in rejection tray.
All the above sorters are placed in series at the ejection chute to confirm the defective capsules are
trapped before further processing. The entire manufacturing is auto process and there is no manual
intervention for any intermediate processing.
After moisture stabilization in the chamber, the capsules are again passed through the loose cap /
double cap sorter, diametrical sorter and loose body sorter. In addition, all capsules are passed
through metal detector before collection in shipper boxes; ensuring 100% quality check
Page | 6
www.acg-associatedcapsules.com
Figure-2 - Schematic for Manufacturing Process Flow
In Process Quality Assurance (IPQA)
IPQA checks for compliance include:
· Colour shade and opacity
· Pre-lock length
· Moisture percentage.
· Pull test
· Brittleness
· Powder stickiness test for clear transparent capsules
· Dimensional parameters after every 4 hours
Assessment of Visual Defects
All the boxes are sampled and checked for visual defects and categorized based on severity of defect
for capsule as a dosage form. Based on defects observed in the sample, all the boxes are graded by
in-process QC inspectors.
Page | 7
www.acg-associatedcapsules.com
Table-1 - Classification & Types of Manufacturing Defects
Categorization
of defects
Lot Size 500,000 and above
Sample size Acceptance
Number
Rejection
Number
AQL% AOQL%
CAPSULE DEFECTS
Critical 1250 0 1 0.01 0.029
Major 1250 1 2 0.04 0.067
Minor 1250 7 8 0.25 0.360
Table-2 - Indication Acceptable Quality Limits
(The AQLs indicated above could be verified on a composite random sample drawn from √k +1
cartons in the shipment, where k = number of cartons in the shipment.)
Printing and Packing
Imprinting of Capsules
Capsules can be printed in linear or circular form, with or without orientation, and in single, double
& even four-colour printing. Pharmaceutical grade ink is used for printing. The capsules are printed
in the printing head. Ink is applied to engraved printing roller. It is roto-gravure type continuous
printing operation, where the print message with ink is transferred from printing roller to rubber
roller and then onto the capsule.
Printed capsules are online passed through loose body sorter and the diametrical sorters to entrap
any loose body and mashed capsules generated during printing operations. The printing machines
are equipped with electronic camera system to detect foreign capsules in the lot.
Assessment of Printing Defects
Printing defects are evaluated based on sample size and acceptance number derived from the ISO
2859 Part I using single sampling Plan-I. 100% of boxes printed are sampled and checked for printing
defects. Accordingly all boxes are graded by IPQA.
Critical defect Major defect Minor defect
Unprinted Illegible print Multiple print
Broken letter
Smudged print
Off register
Ink spot/ink lines
Light/dark print
Critical defects Major defects Minor defects
Cracked/split
Double dip
Holes
Mashed
Short body
String on end
telescoped
Trims,
Uncut cap/body
Bad join
Closed capsules
Double cap
Grease/oil rings
Long body
Long cap
Loose pieces
Major collet pinch
Major punched dome
Major rough cut
Short cap
Thin spots
Bubbles
Dirt marks
Minor collet Pinch
Minor punched dome
Minor rough cut
Minor splits
Scrapes/scratches
Specks
Star ends
Strings
Wrinkles
Page | 8
www.acg-associatedcapsules.com
Table-3 - Classification & Types of Printing Defects
Categorization
of defects
Lot Size 500,000 and above
Sample size Acceptance
Number
Rejection
Number
AQL% AOQL%
PRINT DEFECTS
Critical 1250 0 1 0.01 0.029
Major 1250 2 3 0.065 0.110
Minor 1250 21 22 1.0 1.2
Table-4 - Indication Acceptable Quality Limits
(The AQLs indicated could be verified on a composite random sample drawn from √k +1 cartons in
the shipment, where k = number of cartons in the shipment. Corresponding AQL & AOQL values are
also provided therein.)
Figure-3 - Schematic for Printing Process
Quality Control
Testing program is in place that encompasses specifications, sampling plans and test procedures for
raw materials, packaging materials, in-process materials and finished products.
The quality control lab is equipped to perform the testing. This assures the product meets the
required standard in terms of Quality, Purity and Safety.
Preparatory tests are performed to ascertain suitability of microbial tests applied.Once the packing
of product is completed and confirmed in the system, complete document review and product
review is carried out by the QA team and final confirmation for the release of product is done in
system after complete review.
Page | 9
www.acg-associatedcapsules.com
Figure-4 - Schematic for Final QC Procedure
Page | 10
www.acg-associatedcapsules.com
Table-5 - Specification of Hard Gelatin Capsule Shells as per international capsule manufacturers
TEST SPECIFICATIONS
IDENTIFICATION
Description
Unlocked cylindrical capsules
Colour
Cap As per approved colour shade
Body As per approved colour shade
Print message:
text, colour &
orientation
Cap As per approved artwork
Body As per approved artwork
Identification of gelatin Positive for gelatin
Identification of colorants/iron oxides Conform to approved composition
Identification of Titanium Dioxide Conform to approved composition
PERFORMANCE
Disintegration time in water at 37± 20
C Maximum 15 minutes (with guided disc)
Loss on drying (at 1050
C ± 10
C for minimum
4 hours or to constant weight)
Between 13.0% - 16.0% w/w
Average weight of
capsule shells in mg
(Wt. of 100
capsules/100)
Within
± 7 %
Size 000 00el 00 0xel 0el+ 0el 0
Target 163 130 119 109 108.3 104 96
Range
151.6
-
174.4
120.9
-
139.1
110.7
-
127.3
101.4
-
116.6
100.7
-
115.9
96.7
-
111.3
89.3
-
102.7
Size 1el 1 2el 2 3 4 5
Target 81 76 68.4 63 50 39 28
Range
75.3
-
86.7
70.7
-
81.3
63.6
-
73.2
58.6
-
67.4
46.5
-
53.5
36.3
-
41.7
26.0
-
30.0
PURITY
Odour
No foreign odour after 24 hours when kept at a
temperature between 300
C & 400
C
SAFETY
Sulphated ash Maximum 5 % w/w *
Arsenic Maximum 1 ppm
Lead Maximum 1 ppm
Lubricant content Maximum 0.5 % w/w
Sulphur dioxide Maximum 50 ppm
Mercury Maximum 0.1 ppm
Cadmium Maximum 0.5 ppm
MICROBIAL LIMITS
Total aerobic microbial count Maximum 500 cfu / g
Yeast & mold Maximum 100 cfu / g
Escherichia coli Absent / 1 g
Salmonella Absent / 10 g
Pseudomonas aeruginosa Absent / 1 g
Staphylococcus aureus Absent / 1 g
Page | 11
www.acg-associatedcapsules.com
=================================================================================
About ACG Associated Capsules
ACG Associated Capsules (ACG ACPL) is one of the largest manufacturers of two-piece hard gelatin
capsules in the world. To complement its wide range of hard gelatin capsules, ACG ACPL also
manufactures capsules from 100% natural plant source (Naturecaps®
), capsules for filling liquids and
pastes (FlofitTM
), circular two-colour printed capsules (Brandshield®
3600
), four-colour circular-print
anti-counterfeit capsules (Brandshield®
4C), clinical trial capsules (Clinicaps®
) and many more.
Catering to the global pharmaceutical and dietary supplement industries in over 100 countries, ACG
ACPL produces over 60 billion capsules annually through three plants in and around Mumbai, India,
another plant in Ludbreg, Croatia, and a new state-of-the-art facility in Indore, India. Visit www.acg-
associatedcapsules.com for more information.
Why Us?
• Over five decades of experience with hard capsule production
• Versatile product portfolio; capsules made from a variety of raw materials
• Capsules available in a widest range of 14 sizes; from 000 to 5 (including special sizes)
• Up to four-colour linear or circular printing on capsules
• Sophisticated, state-of-the-art manufacturing facilities
• All regulatory approvals, certifications and standards are maintained, which includes US FDA,
EU, Japan, GMP, WHO, ISO, Pharmacopoeia, Kosher and Halal and more
• Warehousing facilities in multiple global locations
• Global sales and service support
www.acg-associatedcapsules.com
SUMMARY OF DIMENSIONS FOR ACG ASSOCIATED CAPSULES’ HARD GELATIN CAPSULE SHELLS
CAPSULE SIZE 0 00el 0 0xel 0el+ 0el 0 1el 1 2el 2 3 4 5
1. CAPACITY
Body Volume (ml) 1.37 1.02 0.95 0.82 0.78 0.78 0.68 0.54 0.5 0.41 0.37 0.3 0.21 0.1
Capsule capacity (mg) for powder density
0.6 g / cc 822 612 570 492 468 468 408 324 300 246 222 180 126 60
0.8 g / cc 1096 816 760 656 624 624 544 432 400 328 296 240 168 80
1.0 g / c.c 1370 1020 950 820 780 780 680 540 500 410 370 300 210 100
1.2 g / cc 1644 1224 1140 984 936 936 816 648 600 492 444 360 252 120
2. WEIGHT
Avg. wt in mg 163 130 119 109 108.3 104 96 81 76 68.4 63 50 39 28
Tolerance in % ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7
3. LENGTH
Cap Nominal (mm) 13 13 11.8 11.8 12 11.7 10.7 10.5 9.8 9.7 9 8.1 7.2 6.2
Tolerance (mm)* ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4
Body Nominal
(mm)
22.2 22.2 20.2 21.8 21 20.3 18.5 17.7 16.6 16.7 15.2 13.6 12.2 9.3
Tolerance (mm)* ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4
4. OVERALL CLOSED LENGTH
Nominal Joined
length (mm)
25.9 25.5 23.5 24.8 24.2 23.2 21.4 20.4 19.3 19.3 17.8 15.8 14.4 11.4
Tolerance (mm)* ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4
5. NORMAL OUTSIDE DIAMETER
Cap Nominal (mm) 9.96 8.55 8.55 7.66 7.66 7.66 7.66 6.93 6.93 6.37 6.37 5.85 5.33 4.91
Tolerance (mm)* ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03
Body Nominal
(mm)
9.61 8.22 8.22 7.34 7.34 7.34 7.34 6.63 6.63 6.08 6.08 5.57 5.06 4.65
Tolerance (mm)* ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03

More Related Content

What's hot

Ich guidelines for stability studies 2
Ich guidelines for stability studies 2Ich guidelines for stability studies 2
Ich guidelines for stability studies 2
priyanka odela
 
Tablet evaluation and stability studies for tablet
Tablet evaluation and stability studies for tabletTablet evaluation and stability studies for tablet
Tablet evaluation and stability studies for tablet
Rajendra Mahajan Mr.Rajmahajan_9990
 
Process Validation of Liquid Orals
Process Validation of Liquid OralsProcess Validation of Liquid Orals
Process Validation of Liquid Orals
Aasawaree Yadav
 
Dissolution chapter
Dissolution chapter Dissolution chapter
Dissolution chapter
Arshad Khan
 
Design calibration en (1)
Design calibration en (1)Design calibration en (1)
Design calibration en (1)
Ruchi Tiwari
 
ICH Guidelines for stability testing
ICH Guidelines for stability testingICH Guidelines for stability testing
ICH Guidelines for stability testing
AnkitaKawtikwar
 
inactive ingredient guideline
inactive ingredient guidelineinactive ingredient guideline
inactive ingredient guideline
Saroj Makwana
 
IPQC Tests for capsules As per IP, BP & USP
IPQC Tests for capsules As per IP, BP & USPIPQC Tests for capsules As per IP, BP & USP
IPQC Tests for capsules As per IP, BP & USP
Pramod Ramane
 
stability tests for pharmaceutical products
stability tests for pharmaceutical productsstability tests for pharmaceutical products
stability tests for pharmaceutical productsalaaalfayez
 
IPQC tests for Parenterals
IPQC tests for ParenteralsIPQC tests for Parenterals
IPQC tests for Parenterals
praptipattanayak
 
Quality control test for powders
Quality control test for powdersQuality control test for powders
Quality control test for powders
Parimala Gattupalli
 
Inprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsInprocess as per usp ip bp tablets
Inprocess as per usp ip bp tablets
Deepak Jain
 
ICH-Stability of finished products
ICH-Stability of finished productsICH-Stability of finished products
ICH-Stability of finished products
Arshad Khan
 
Capsule and its annovation
Capsule and its annovationCapsule and its annovation
Capsule and its annovation
Vijay Gajera
 
IPQC and FPQC for tablets
IPQC and FPQC for tabletsIPQC and FPQC for tablets
IPQC and FPQC for tablets
Mukesh Patil
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenteralsceutics1315
 
Preformulation stability study
Preformulation stability studyPreformulation stability study
Preformulation stability study
Arabinda Changmai
 
IPQC for capsule.
IPQC for capsule.IPQC for capsule.
IPQC for capsule.
ganpat420
 
in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals
Henisha Patel
 

What's hot (20)

Ich guidelines for stability studies 2
Ich guidelines for stability studies 2Ich guidelines for stability studies 2
Ich guidelines for stability studies 2
 
Tablet evaluation and stability studies for tablet
Tablet evaluation and stability studies for tabletTablet evaluation and stability studies for tablet
Tablet evaluation and stability studies for tablet
 
Process Validation of Liquid Orals
Process Validation of Liquid OralsProcess Validation of Liquid Orals
Process Validation of Liquid Orals
 
Dissolution chapter
Dissolution chapter Dissolution chapter
Dissolution chapter
 
Design calibration en (1)
Design calibration en (1)Design calibration en (1)
Design calibration en (1)
 
ICH Guidelines for stability testing
ICH Guidelines for stability testingICH Guidelines for stability testing
ICH Guidelines for stability testing
 
inactive ingredient guideline
inactive ingredient guidelineinactive ingredient guideline
inactive ingredient guideline
 
IPQC Tests for capsules As per IP, BP & USP
IPQC Tests for capsules As per IP, BP & USPIPQC Tests for capsules As per IP, BP & USP
IPQC Tests for capsules As per IP, BP & USP
 
stability tests for pharmaceutical products
stability tests for pharmaceutical productsstability tests for pharmaceutical products
stability tests for pharmaceutical products
 
IPQC tests for Parenterals
IPQC tests for ParenteralsIPQC tests for Parenterals
IPQC tests for Parenterals
 
Quality control test for powders
Quality control test for powdersQuality control test for powders
Quality control test for powders
 
Inprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsInprocess as per usp ip bp tablets
Inprocess as per usp ip bp tablets
 
ICH-Stability of finished products
ICH-Stability of finished productsICH-Stability of finished products
ICH-Stability of finished products
 
Capsule and its annovation
Capsule and its annovationCapsule and its annovation
Capsule and its annovation
 
IPQC and FPQC for tablets
IPQC and FPQC for tabletsIPQC and FPQC for tablets
IPQC and FPQC for tablets
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenterals
 
PHOTOSTABILITY TESTING SEM I SEMINAR
PHOTOSTABILITY TESTING SEM I SEMINARPHOTOSTABILITY TESTING SEM I SEMINAR
PHOTOSTABILITY TESTING SEM I SEMINAR
 
Preformulation stability study
Preformulation stability studyPreformulation stability study
Preformulation stability study
 
IPQC for capsule.
IPQC for capsule.IPQC for capsule.
IPQC for capsule.
 
in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals
 

Viewers also liked

Hard gelatin capsules ppt B
Hard gelatin  capsules ppt BHard gelatin  capsules ppt B
Hard gelatin capsules ppt BMohammed Saleem
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
Ramya priya
 
Capsules
CapsulesCapsules
Capsules
Sagar Savale
 
MSI SUPPLY PIPE CHART
MSI SUPPLY PIPE CHARTMSI SUPPLY PIPE CHART
MSI SUPPLY PIPE CHART
Jennifer Villalon
 
Orientation Report Latest
Orientation Report LatestOrientation Report Latest
Orientation Report Latestsindhu rajper
 
Hard gelatin capsules
Hard gelatin capsulesHard gelatin capsules
Hard gelatin capsules
hussanrocks
 
Pdf seminar final
Pdf seminar finalPdf seminar final
Pdf seminar final
Baliram Musale
 
Process Flow of Pharma Companies
Process Flow of Pharma CompaniesProcess Flow of Pharma Companies
Process Flow of Pharma Companies
Spine Software Systems Pvt. Ltd.
 
Pharmaceutical Capsules
Pharmaceutical CapsulesPharmaceutical Capsules
Pharmaceutical Capsulesjojohen
 
Capsule @ppm
Capsule @ppmCapsule @ppm
Capsule @ppm
prashant mane
 

Viewers also liked (13)

Hard gelatin capsules ppt B
Hard gelatin  capsules ppt BHard gelatin  capsules ppt B
Hard gelatin capsules ppt B
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
 
Capsules
CapsulesCapsules
Capsules
 
MSI SUPPLY PIPE CHART
MSI SUPPLY PIPE CHARTMSI SUPPLY PIPE CHART
MSI SUPPLY PIPE CHART
 
Orientation Report Latest
Orientation Report LatestOrientation Report Latest
Orientation Report Latest
 
Hard gelatin capsules
Hard gelatin capsulesHard gelatin capsules
Hard gelatin capsules
 
Pdf seminar final
Pdf seminar finalPdf seminar final
Pdf seminar final
 
Capsule
CapsuleCapsule
Capsule
 
Process Flow of Pharma Companies
Process Flow of Pharma CompaniesProcess Flow of Pharma Companies
Process Flow of Pharma Companies
 
Pharmaceutical Capsules
Pharmaceutical CapsulesPharmaceutical Capsules
Pharmaceutical Capsules
 
Capsules
CapsulesCapsules
Capsules
 
Capsule's
Capsule'sCapsule's
Capsule's
 
Capsule @ppm
Capsule @ppmCapsule @ppm
Capsule @ppm
 

Similar to A Primer on Hard Gelatin Capsule Manufacturing

Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulolPilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
KhushbooKunkulol
 
PMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdf
PMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdfPMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdf
PMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdf
PMG Engineering Private Limited
 
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
PrakashKumar721
 
Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...
Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...
Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...
ijsrd.com
 
Pilot Plant scale up techniques in Pharmaceutical industry
Pilot Plant scale up techniques in Pharmaceutical industryPilot Plant scale up techniques in Pharmaceutical industry
Pilot Plant scale up techniques in Pharmaceutical industry
Shubham Sharma
 
Production process of hard gelatin capsule
Production process of hard gelatin capsuleProduction process of hard gelatin capsule
Production process of hard gelatin capsule
prishr
 
Pilot plant Techniques and Product consideration for liquid dosage forms.
Pilot plant Techniques and Product consideration for liquid dosage forms.Pilot plant Techniques and Product consideration for liquid dosage forms.
Pilot plant Techniques and Product consideration for liquid dosage forms.
D.R. Chandravanshi
 
Manufacturing Operations And Control In Pharmaceuticals
Manufacturing  Operations And Control In PharmaceuticalsManufacturing  Operations And Control In Pharmaceuticals
Manufacturing Operations And Control In Pharmaceuticals
Dr. vitthalrao vikhe patil foundations college of pharmacy , viladghat , ahmednagar.
 
Pilot final 1
Pilot final 1Pilot final 1
Pilot final 1
PrakruthiJagadesh
 
Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.
Neha Roy
 
Article 98050
Article 98050Article 98050
Article 98050
Eka Selvina
 
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
shiv
 
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docx
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docxInternship training report on Dr. Milton Laboratories Pvt. Ltd..docx
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docx
RajaKarthikeyan4
 
Industrial training report / Summer Vacation Report / Institutional Training ...
Industrial training report / Summer Vacation Report / Institutional Training ...Industrial training report / Summer Vacation Report / Institutional Training ...
Industrial training report / Summer Vacation Report / Institutional Training ...
RajaKrishnan M
 
ICHQ5C
ICHQ5CICHQ5C
PILOT PLANT pratik.pptx
PILOT PLANT pratik.pptxPILOT PLANT pratik.pptx
PILOT PLANT pratik.pptx
Pratik434909
 
Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...
Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...
Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...
PMG Engineering Private Limited
 
In pharmaceutical engineering.docx project
In pharmaceutical engineering.docx projectIn pharmaceutical engineering.docx project
In pharmaceutical engineering.docx project
ssuser2b28e8
 
Capsule Gp A
Capsule Gp ACapsule Gp A
Capsule Gp A
Tehmina Adnan
 

Similar to A Primer on Hard Gelatin Capsule Manufacturing (20)

Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulolPilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
 
PMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdf
PMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdfPMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdf
PMG Newsletter (Volume 2. Issue 28)- DIGITAL.pdf
 
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
 
Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...
Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...
Waste Minimization and Energy Conservation in Gelatin Production by Raw Mater...
 
Pilot Plant scale up techniques in Pharmaceutical industry
Pilot Plant scale up techniques in Pharmaceutical industryPilot Plant scale up techniques in Pharmaceutical industry
Pilot Plant scale up techniques in Pharmaceutical industry
 
Production process of hard gelatin capsule
Production process of hard gelatin capsuleProduction process of hard gelatin capsule
Production process of hard gelatin capsule
 
A PROJECT REPORT ON
A PROJECT REPORT ONA PROJECT REPORT ON
A PROJECT REPORT ON
 
Pilot plant Techniques and Product consideration for liquid dosage forms.
Pilot plant Techniques and Product consideration for liquid dosage forms.Pilot plant Techniques and Product consideration for liquid dosage forms.
Pilot plant Techniques and Product consideration for liquid dosage forms.
 
Manufacturing Operations And Control In Pharmaceuticals
Manufacturing  Operations And Control In PharmaceuticalsManufacturing  Operations And Control In Pharmaceuticals
Manufacturing Operations And Control In Pharmaceuticals
 
Pilot final 1
Pilot final 1Pilot final 1
Pilot final 1
 
Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.
 
Article 98050
Article 98050Article 98050
Article 98050
 
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
 
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docx
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docxInternship training report on Dr. Milton Laboratories Pvt. Ltd..docx
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docx
 
Industrial training report / Summer Vacation Report / Institutional Training ...
Industrial training report / Summer Vacation Report / Institutional Training ...Industrial training report / Summer Vacation Report / Institutional Training ...
Industrial training report / Summer Vacation Report / Institutional Training ...
 
ICHQ5C
ICHQ5CICHQ5C
ICHQ5C
 
PILOT PLANT pratik.pptx
PILOT PLANT pratik.pptxPILOT PLANT pratik.pptx
PILOT PLANT pratik.pptx
 
Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...
Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...
Introduction to Fruit Pulp Processing- Usage, Processing Unit, Issues, Conclu...
 
In pharmaceutical engineering.docx project
In pharmaceutical engineering.docx projectIn pharmaceutical engineering.docx project
In pharmaceutical engineering.docx project
 
Capsule Gp A
Capsule Gp ACapsule Gp A
Capsule Gp A
 

Recently uploaded

The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
Jemma Hussein Allen
 
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™
UiPathCommunity
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024
Pierluigi Pugliese
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
Free Complete Python - A step towards Data Science
Free Complete Python - A step towards Data ScienceFree Complete Python - A step towards Data Science
Free Complete Python - A step towards Data Science
RinaMondal9
 
A tale of scale & speed: How the US Navy is enabling software delivery from l...
A tale of scale & speed: How the US Navy is enabling software delivery from l...A tale of scale & speed: How the US Navy is enabling software delivery from l...
A tale of scale & speed: How the US Navy is enabling software delivery from l...
sonjaschweigert1
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
Generative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionGenerative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to Production
Aggregage
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
91mobiles
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Thierry Lestable
 
Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?
Nexer Digital
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 
Quantum Computing: Current Landscape and the Future Role of APIs
Quantum Computing: Current Landscape and the Future Role of APIsQuantum Computing: Current Landscape and the Future Role of APIs
Quantum Computing: Current Landscape and the Future Role of APIs
Vlad Stirbu
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
OnBoard
 

Recently uploaded (20)

The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
 
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
Free Complete Python - A step towards Data Science
Free Complete Python - A step towards Data ScienceFree Complete Python - A step towards Data Science
Free Complete Python - A step towards Data Science
 
A tale of scale & speed: How the US Navy is enabling software delivery from l...
A tale of scale & speed: How the US Navy is enabling software delivery from l...A tale of scale & speed: How the US Navy is enabling software delivery from l...
A tale of scale & speed: How the US Navy is enabling software delivery from l...
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
Generative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionGenerative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to Production
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
 
Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 
Quantum Computing: Current Landscape and the Future Role of APIs
Quantum Computing: Current Landscape and the Future Role of APIsQuantum Computing: Current Landscape and the Future Role of APIs
Quantum Computing: Current Landscape and the Future Role of APIs
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
 

A Primer on Hard Gelatin Capsule Manufacturing

  • 1. www.acg-associatedcapsules.com ACG Associated Capsules’ A Primer on Hard Gelatin Capsule Manufacturing Understanding what goes into making high-quality empty hard gelatin capsules.
  • 2. Page | 2 www.acg-associatedcapsules.com Introduction Hard gelatin capsule shells are used as soluble containers for incorporation of drugs or nutritional supplements, usually in the form of powders, pellets or granules in the healthcare industry. They are commonly intended for oral administration having its advantages over other dosage forms that are used widely by pharmaceutical companies to develop different medicaments and ensure stability of the product throughout the shelf life. Since it serves as a major excipient for the manufacture of pharmaceutical products, the quality attributes of hard capsule shells is very vital for performance and stability of the final product. Pharmaceutical products are categorized as high quality and high risk product administered to fight various types of acute and chronic illnesses where the performance of the product should be reproducible every time it is administered. The capsule shell consists of two cylindrical parts i.e. the cap and body; both are open at one extreme. Other extreme of both is hemispherical; the open end of cap overlaps the open end of body and maintains a closure with a typical lock system. Hence, it is very important that the product achieves the label claim as set forth and is not contaminated and readily available to the patients. Benchmarking of developments and manufacturing processes in the pharmaceutical industry as against other industries led to the concept of Quality by Design or QbD. Over the past few years, QbD has gained considerable acceptance throughout pharmaceutical industry and has been successfully applied. The key quality attributes of capsules that determine the process ability on the high speed filling machine are the dimensional characteristics and weight variability. The potential variations of empty hard capsules as an input material and its potential impact on finished product quality has been studied and high consistency within the specification of the critical quality parameters is confirmed. Annual product quality review needs to be performed using defined sampling size against set of verification criteria. The built-in quality approach begins at the development stage of new product where even factors impacting the performance of hard capsules i.e. formulation, filling machine type, etc., is given due consideration. The selection of proper raw material, the process validations and stability studies are to be conducted for suitability. The process conditions should be maintained along with appropriate in-process quality checks. Final release of product can be done by QA after product and document review. The data on process capability, trends of quality parameters, technical specification and the evaluation procedure should be maintained and submitted based on the current level of quality standards. Manufacturing of Hard Gelatin Capsule Shells Raw Materials The manufacture of hard gelatin capsule shells is by physical molding process where gelatin & water are the basic raw materials required. Colorants & opacifiers are optional and are used as per requirement. Gelatin Gelatin from bovine source is the main raw material used in the manufacturing of hard capsule shells. Bovine gelatin used is derived from bones and hides of healthy animals that have been certified as fit for human consumption by a veterinary official at slaughtering. The tissues used in the manufacture of gelatin are free from specified risk material. It should be ensured that bovine gelatin conforms to TSE/BSE regulation as applicable to the country of use. All gelatin used must confirm to applicable pharmacopoeia and food regulation like: · Regulation (EC) No 999/2001
  • 3. Page | 3 www.acg-associatedcapsules.com · Regulation (EC) No 853 2004 · Commission directive 2003/63/EC and European Pharmacopoeia - 1483 evidenced by certificate of suitability. · USFDA Sept 1997 Guidance to industry for sourcing and processing of gelatin to reduce the potential risk posed by BSE in FDA regulated product. · USFDA 21 CFR parts 189, 589, 700 pertaining to prohibited cattle material in human food, drugs and cosmetics and animal feeds. · USFDA 9 CFR part 94.18 pertaining to restriction on important edible products from ruminants due to BSE. · USFDA 9 CFR part 94.19 on gelatin from ruminants that have not been in any region where BSE exists Food Colors Food colorants applicable to the regulatory standards must be used for the manufacturing of hard gelatin capsules. Colors that require FDA approval as per customer intent bear the FDA lot number. Colors not requiring FDA approval, as per local regulation or customer, should be accompanied by certificate of analysis complying with applicable standard. Stock solutions of food colors are prepared and the concentration of solution is checked by QC, and suggested for any corrections required. As per the recipe, known concentration of color stock solutions are added to mucilage to achieve the required shade conforming to the primary master sample. Purified Water Purified water conforming to applicable pharmacopoeia is to be used for preparing mucilage for capsule manufacturing. The pre-treatment of water is carried out with sodium hypochlorite and flocculating agents. The pre-treated water is filtered through multigrain, sand filters softened and demineralized. Demineralized (DM) water is monitored for conductivity and pH. DM water plant is interlocked for regeneration when pH and conductivity is out of limit. UV lamps are installed at critical points for control of microbial contamination. The DM water is pumped through 0.2 µ filters. The distribution and storage is non-corrosive stainless steel. The purified water is maintained at temperature of 82+ 2 degrees and is under continuous hot loop circulation. In addition, raw water is checked for hardness daily. User points are also sampled and tested for Micro, hardness, pH, conductivity, potability on a daily and weekly basis. Material Movement After receiving the material, it is quarantined bearing appropriate sticker and the lot information. Containers are sampled as per the sampling plan by QC under reverse laminar air flow one at a time and labeled. The sampled material is tested for compliance to the defined pharmacopoeial and in house specifications. The approved materials are identified by appropriate approved labeling which mentions the analytical report number and the reassessment date. Storage of quarantine and approved material is segregated. Only raw materials, which are approved by QC and within the shelf life, are dispensed and issued to production. The dispensing is carried out based on system generated recipe for the particular batch; this is done on suitable calibrated weighing scale. Product is identified by labels, identification cards, and tags at all stages of production. Raw materials that do not confirm to specifications are labeled with rejected label and stored segregated in secured manner to prevent inadvertent use till material is returned back to the vendor. All stages of bulk manufacturing area are designated for in-process rejects and are kept under control.
  • 4. Page | 4 www.acg-associatedcapsules.com PROCESS CONTROLS Figure-1 - Schematic of Raw Material Movement Prior to Dipping Bulk Manufacturing Mucilage Preparation The mucilage is prepared in stainless steel jacketed vessels with impeller for uniform mixing of the additives in controlled environment conditions. The clear transparent gelatin solution is withdrawn in feed tanks that are also stainless steel jacketed vessel. Each color shade can be identified by unique identification number and the recipe is stored in the system. The colorants are added as per the recipe in the feed tank and the final shade is approved by QA. The temperature of gelatin solution is maintained at 50 +1 degree throughout the process. The gelatin solution should be converted within 18 hours to ensure there is no risk of microbial growth in the solution. Adequate in-process checks are done to ensure right quality of mucilage is issued for manufacturing. Equipment surfaces that come in contact with in-process material/finished product, should be non- reactive, non-corrosive and non-additive. The pin bars have typical lock pattern and vents engraved on them for proper locking and to facilitate displacement of air at the time of closing on high-speed filling machines. The cap of capsule also has pre-locks to reduce possibility of premature separation of cap and body during transportation and conveying prior to filling. The hard gelatin capsule machine comprises four main sections:
  • 5. Page | 5 www.acg-associatedcapsules.com Dipping Section The dip baths hold the gelatin solution for molding. The design of the dip bath is developed to ensure proper weight spread. The dip bath’s central and parellal functions are monitored to ensure equal picking up of gelatin at all the four corners of the dipping section. The pin bars undergo one- and-a-half rotation to ensure uniform distribution of gelatin solution in the dome portion. The pin bars are reconditioned and polished before re-dipping in the gelatin solution. Drying Section The dipped pin bars form stacks and are carried on conveyor to drying section. There are different drying hoods in the drying section. The temperature and relative humidity in each drying zone is controlled by maintaining the dew point for proper drying of capsule. Auto Head Section The dried shells are carried on a conveyor into the auto head section. The dried capsules are stripped, cut and joined in this section. The cap and body are held separately in the collet ring and are cut with specially-designed ceramic blades to the required length. The frequency of blade checking and replacement is defined and closely monitored. Air Transfer System The capsules manufactured are transferred to moisture stabilization chamber through venturi. The capsules are flushed with controlled air for stabilization of moisture. The capsules, after joining, are ejected on series of mechanical sorter where defects generated as a virtue of process are trapped and prevented from further processing. Sorters such as: Diametrical Sorter: The diametrical sorter is a go-no-go sieve with openings of the size of cap diameter, allowing any damaged or disfigured capsules are trapped. Nail Bed Sorter: Usually, the ring created after the cap and body are cut is sucked through vacuum. However, if not trapped by vacuum, these rings can be trapped in the bed of nails installed. The nail bed sorter also catches any loose caps or bodies. Loose Body Sorter: This sorter consists of a rotating disc with spacers between two discs, exactly the size more than the outer diameter of body and slightly less than the inner diameter of cap. Due to the rotational movement, only good capsules get carried over to the hopper of venturi. All loose bodies are collected in rejection tray. All the above sorters are placed in series at the ejection chute to confirm the defective capsules are trapped before further processing. The entire manufacturing is auto process and there is no manual intervention for any intermediate processing. After moisture stabilization in the chamber, the capsules are again passed through the loose cap / double cap sorter, diametrical sorter and loose body sorter. In addition, all capsules are passed through metal detector before collection in shipper boxes; ensuring 100% quality check
  • 6. Page | 6 www.acg-associatedcapsules.com Figure-2 - Schematic for Manufacturing Process Flow In Process Quality Assurance (IPQA) IPQA checks for compliance include: · Colour shade and opacity · Pre-lock length · Moisture percentage. · Pull test · Brittleness · Powder stickiness test for clear transparent capsules · Dimensional parameters after every 4 hours Assessment of Visual Defects All the boxes are sampled and checked for visual defects and categorized based on severity of defect for capsule as a dosage form. Based on defects observed in the sample, all the boxes are graded by in-process QC inspectors.
  • 7. Page | 7 www.acg-associatedcapsules.com Table-1 - Classification & Types of Manufacturing Defects Categorization of defects Lot Size 500,000 and above Sample size Acceptance Number Rejection Number AQL% AOQL% CAPSULE DEFECTS Critical 1250 0 1 0.01 0.029 Major 1250 1 2 0.04 0.067 Minor 1250 7 8 0.25 0.360 Table-2 - Indication Acceptable Quality Limits (The AQLs indicated above could be verified on a composite random sample drawn from √k +1 cartons in the shipment, where k = number of cartons in the shipment.) Printing and Packing Imprinting of Capsules Capsules can be printed in linear or circular form, with or without orientation, and in single, double & even four-colour printing. Pharmaceutical grade ink is used for printing. The capsules are printed in the printing head. Ink is applied to engraved printing roller. It is roto-gravure type continuous printing operation, where the print message with ink is transferred from printing roller to rubber roller and then onto the capsule. Printed capsules are online passed through loose body sorter and the diametrical sorters to entrap any loose body and mashed capsules generated during printing operations. The printing machines are equipped with electronic camera system to detect foreign capsules in the lot. Assessment of Printing Defects Printing defects are evaluated based on sample size and acceptance number derived from the ISO 2859 Part I using single sampling Plan-I. 100% of boxes printed are sampled and checked for printing defects. Accordingly all boxes are graded by IPQA. Critical defect Major defect Minor defect Unprinted Illegible print Multiple print Broken letter Smudged print Off register Ink spot/ink lines Light/dark print Critical defects Major defects Minor defects Cracked/split Double dip Holes Mashed Short body String on end telescoped Trims, Uncut cap/body Bad join Closed capsules Double cap Grease/oil rings Long body Long cap Loose pieces Major collet pinch Major punched dome Major rough cut Short cap Thin spots Bubbles Dirt marks Minor collet Pinch Minor punched dome Minor rough cut Minor splits Scrapes/scratches Specks Star ends Strings Wrinkles
  • 8. Page | 8 www.acg-associatedcapsules.com Table-3 - Classification & Types of Printing Defects Categorization of defects Lot Size 500,000 and above Sample size Acceptance Number Rejection Number AQL% AOQL% PRINT DEFECTS Critical 1250 0 1 0.01 0.029 Major 1250 2 3 0.065 0.110 Minor 1250 21 22 1.0 1.2 Table-4 - Indication Acceptable Quality Limits (The AQLs indicated could be verified on a composite random sample drawn from √k +1 cartons in the shipment, where k = number of cartons in the shipment. Corresponding AQL & AOQL values are also provided therein.) Figure-3 - Schematic for Printing Process Quality Control Testing program is in place that encompasses specifications, sampling plans and test procedures for raw materials, packaging materials, in-process materials and finished products. The quality control lab is equipped to perform the testing. This assures the product meets the required standard in terms of Quality, Purity and Safety. Preparatory tests are performed to ascertain suitability of microbial tests applied.Once the packing of product is completed and confirmed in the system, complete document review and product review is carried out by the QA team and final confirmation for the release of product is done in system after complete review.
  • 9. Page | 9 www.acg-associatedcapsules.com Figure-4 - Schematic for Final QC Procedure
  • 10. Page | 10 www.acg-associatedcapsules.com Table-5 - Specification of Hard Gelatin Capsule Shells as per international capsule manufacturers TEST SPECIFICATIONS IDENTIFICATION Description Unlocked cylindrical capsules Colour Cap As per approved colour shade Body As per approved colour shade Print message: text, colour & orientation Cap As per approved artwork Body As per approved artwork Identification of gelatin Positive for gelatin Identification of colorants/iron oxides Conform to approved composition Identification of Titanium Dioxide Conform to approved composition PERFORMANCE Disintegration time in water at 37± 20 C Maximum 15 minutes (with guided disc) Loss on drying (at 1050 C ± 10 C for minimum 4 hours or to constant weight) Between 13.0% - 16.0% w/w Average weight of capsule shells in mg (Wt. of 100 capsules/100) Within ± 7 % Size 000 00el 00 0xel 0el+ 0el 0 Target 163 130 119 109 108.3 104 96 Range 151.6 - 174.4 120.9 - 139.1 110.7 - 127.3 101.4 - 116.6 100.7 - 115.9 96.7 - 111.3 89.3 - 102.7 Size 1el 1 2el 2 3 4 5 Target 81 76 68.4 63 50 39 28 Range 75.3 - 86.7 70.7 - 81.3 63.6 - 73.2 58.6 - 67.4 46.5 - 53.5 36.3 - 41.7 26.0 - 30.0 PURITY Odour No foreign odour after 24 hours when kept at a temperature between 300 C & 400 C SAFETY Sulphated ash Maximum 5 % w/w * Arsenic Maximum 1 ppm Lead Maximum 1 ppm Lubricant content Maximum 0.5 % w/w Sulphur dioxide Maximum 50 ppm Mercury Maximum 0.1 ppm Cadmium Maximum 0.5 ppm MICROBIAL LIMITS Total aerobic microbial count Maximum 500 cfu / g Yeast & mold Maximum 100 cfu / g Escherichia coli Absent / 1 g Salmonella Absent / 10 g Pseudomonas aeruginosa Absent / 1 g Staphylococcus aureus Absent / 1 g
  • 11. Page | 11 www.acg-associatedcapsules.com ================================================================================= About ACG Associated Capsules ACG Associated Capsules (ACG ACPL) is one of the largest manufacturers of two-piece hard gelatin capsules in the world. To complement its wide range of hard gelatin capsules, ACG ACPL also manufactures capsules from 100% natural plant source (Naturecaps® ), capsules for filling liquids and pastes (FlofitTM ), circular two-colour printed capsules (Brandshield® 3600 ), four-colour circular-print anti-counterfeit capsules (Brandshield® 4C), clinical trial capsules (Clinicaps® ) and many more. Catering to the global pharmaceutical and dietary supplement industries in over 100 countries, ACG ACPL produces over 60 billion capsules annually through three plants in and around Mumbai, India, another plant in Ludbreg, Croatia, and a new state-of-the-art facility in Indore, India. Visit www.acg- associatedcapsules.com for more information. Why Us? • Over five decades of experience with hard capsule production • Versatile product portfolio; capsules made from a variety of raw materials • Capsules available in a widest range of 14 sizes; from 000 to 5 (including special sizes) • Up to four-colour linear or circular printing on capsules • Sophisticated, state-of-the-art manufacturing facilities • All regulatory approvals, certifications and standards are maintained, which includes US FDA, EU, Japan, GMP, WHO, ISO, Pharmacopoeia, Kosher and Halal and more • Warehousing facilities in multiple global locations • Global sales and service support
  • 12. www.acg-associatedcapsules.com SUMMARY OF DIMENSIONS FOR ACG ASSOCIATED CAPSULES’ HARD GELATIN CAPSULE SHELLS CAPSULE SIZE 0 00el 0 0xel 0el+ 0el 0 1el 1 2el 2 3 4 5 1. CAPACITY Body Volume (ml) 1.37 1.02 0.95 0.82 0.78 0.78 0.68 0.54 0.5 0.41 0.37 0.3 0.21 0.1 Capsule capacity (mg) for powder density 0.6 g / cc 822 612 570 492 468 468 408 324 300 246 222 180 126 60 0.8 g / cc 1096 816 760 656 624 624 544 432 400 328 296 240 168 80 1.0 g / c.c 1370 1020 950 820 780 780 680 540 500 410 370 300 210 100 1.2 g / cc 1644 1224 1140 984 936 936 816 648 600 492 444 360 252 120 2. WEIGHT Avg. wt in mg 163 130 119 109 108.3 104 96 81 76 68.4 63 50 39 28 Tolerance in % ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 ± 7 3. LENGTH Cap Nominal (mm) 13 13 11.8 11.8 12 11.7 10.7 10.5 9.8 9.7 9 8.1 7.2 6.2 Tolerance (mm)* ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 Body Nominal (mm) 22.2 22.2 20.2 21.8 21 20.3 18.5 17.7 16.6 16.7 15.2 13.6 12.2 9.3 Tolerance (mm)* ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 4. OVERALL CLOSED LENGTH Nominal Joined length (mm) 25.9 25.5 23.5 24.8 24.2 23.2 21.4 20.4 19.3 19.3 17.8 15.8 14.4 11.4 Tolerance (mm)* ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 ± 0.4 5. NORMAL OUTSIDE DIAMETER Cap Nominal (mm) 9.96 8.55 8.55 7.66 7.66 7.66 7.66 6.93 6.93 6.37 6.37 5.85 5.33 4.91 Tolerance (mm)* ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 Body Nominal (mm) 9.61 8.22 8.22 7.34 7.34 7.34 7.34 6.63 6.63 6.08 6.08 5.57 5.06 4.65 Tolerance (mm)* ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03 ± 0.03